secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001213900-25-116985
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea raises ~$60M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds of $60.0M; net proceeds of ~$54.9M after fees and expenses.
- Offering priced at $0.75 per share/warrant; 80M shares (or pre-funded warrants) sold.
- Led by healthcare investors including Vivo Capital, Janus Henderson, Coastlands Capital.
- Insiders (CEO, CFO, board members) bought 400k shares at same price.
- Cash runway extended through at least first half 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/0001213900-25-116985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/ea0267824-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-116985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer